Compass Financial Management’s Oruka Therapeutics ORKA Stock Holding History
Bought
Maintained
Sold
Other funds holding ORKA
Compass Financial Management's ORKA Position: Q3 2026 in Review
Compass Financial Management sold out of Oruka Therapeutics (ORKA) in Q3 2026, closing a stake of 38 shares — an estimated $3.73K sold.
Compass Financial Management first reported a position in ORKA in Q2 2026 and held it in 1 quarter. The position peaked at $3.73K in Q2 2026. 259 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.
- Compass Financial Management reported no remaining Oruka Therapeutics position as of Q3 2026 after selling out during the quarter.
- Compass Financial Management sold 38 Oruka Therapeutics shares in Q3 2026, an estimated $3.73K.
- Compass Financial Management first reported a position in Oruka Therapeutics in Q2 2026 and held it in 1 quarter.
- Compass Financial Management's Oruka Therapeutics position peaked at $3.73K in Q2 2026.
- 259 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.
Based on Compass Financial Management's 13F filing for Q3 2026, filed 30 Oct 2026.